We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Aetna (AET) and Units Receive Rating Action from A.M. Best
Read MoreHide Full Article
Aetna Inc. and its affiliates recently received rating actions from A.M. Best. The health insurer’s issuer credit rating (ICR) was lowered to “bbb” from “bbb+” and it was removed from under review with negative implications. Concurrently, the credit rating giant reiterated the financial strength ratings (FSR) of A (Excellent) of Aetna Life Insurance Company and other subsidiaries.
Additionally, issue ratings of the existing debt of Aetna and Coventry Health Care Inc.’s senior unsecured notes were revised to “bbb” from “bbb+”. Another unit – Aetna Insurance Company of Connecticut – saw its FSR lowered to B++ (Good) from A (Excellent) and ICR downgraded to “bbb” from “a”. Both these units were removed from under review with negative implications.
Notably, the ratings carry stable outlook.
The rating downgrade on Aetna reflects a surge in financial ratio due to the issuance of $13 billion debt for the Humana Inc. (HUM - Free Report) buyout. This not only limited the firm’s borrowing capacity but also lowered interest coverage ratio. Also, the company remains exposed to integration risks, while its goodwill and intangibles are expected to rise to more than total equity.
Nevertheless, A.M. Best notes Aetna has been delivering sustained solid operating results fueled by low medical cost trends and improved operational efficiencies besides solid cash flows and health insurance and group insurance operations offering a diversified revenue stream.
Aetna carries a Zacks Rank of #3 (Hold). Some better-ranked stocks in the medical sector are Magellan Health, Inc. and AMN Healthcare Services Inc. . Both these stocks sport Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Aetna (AET) and Units Receive Rating Action from A.M. Best
Aetna Inc. and its affiliates recently received rating actions from A.M. Best. The health insurer’s issuer credit rating (ICR) was lowered to “bbb” from “bbb+” and it was removed from under review with negative implications. Concurrently, the credit rating giant reiterated the financial strength ratings (FSR) of A (Excellent) of Aetna Life Insurance Company and other subsidiaries.
Additionally, issue ratings of the existing debt of Aetna and Coventry Health Care Inc.’s senior unsecured notes were revised to “bbb” from “bbb+”. Another unit – Aetna Insurance Company of Connecticut – saw its FSR lowered to B++ (Good) from A (Excellent) and ICR downgraded to “bbb” from “a”. Both these units were removed from under review with negative implications.
Notably, the ratings carry stable outlook.
The rating downgrade on Aetna reflects a surge in financial ratio due to the issuance of $13 billion debt for the Humana Inc. (HUM - Free Report) buyout. This not only limited the firm’s borrowing capacity but also lowered interest coverage ratio. Also, the company remains exposed to integration risks, while its goodwill and intangibles are expected to rise to more than total equity.
Nevertheless, A.M. Best notes Aetna has been delivering sustained solid operating results fueled by low medical cost trends and improved operational efficiencies besides solid cash flows and health insurance and group insurance operations offering a diversified revenue stream.
AETNA INC-NEW Price
AETNA INC-NEW Price | AETNA INC-NEW Quote
Zacks Rank and Stocks to Consider
Aetna carries a Zacks Rank of #3 (Hold). Some better-ranked stocks in the medical sector are Magellan Health, Inc. and AMN Healthcare Services Inc. . Both these stocks sport Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>